{"id":"https://openalex.org/W3099387352","doi":"https://doi.org/10.2147/dmso.s216054","title":"Long-Acting Injectable GLP-1 Receptor Agonists for the Treatment of Adults with Type 2 Diabetes: Perspectives from Clinical Practice","display_name":"Long-Acting Injectable GLP-1 Receptor Agonists for the Treatment of Adults with Type 2 Diabetes: Perspectives from Clinical Practice","alternate_titles":[],"publication_year":2020,"publication_date":"2020-11-01","ids":{"openalex":"https://openalex.org/W3099387352","doi":"https://doi.org/10.2147/dmso.s216054","mag":"3099387352","pmid":"https://pubmed.ncbi.nlm.nih.gov/33204129","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7665457"},"language":"en","primary_location":{"id":"doi:10.2147/dmso.s216054","doi":"https://doi.org/10.2147/dmso.s216054","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s216054","pdf_url":"https://www.dovepress.com/getfile.php?fileID=63494","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3099387352"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=63494","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087917482","display_name":"Mario Luca Morieri","orcid":"https://orcid.org/0000-0001-6864-0547","observed_orcids":["https://orcid.org/0000-0001-6864-0547"]},"institutions":[{"id":"https://openalex.org/I138689650","display_name":"University of Padua","ror":"https://ror.org/00240q980","country_code":"IT","type":"education","lineage":["https://openalex.org/I138689650"]}],"countries":["IT"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Mario Luca Morieri","raw_affiliation_strings":["Department of Medicine, University of Padova, Padova 35128, Italy"],"raw_orcid":"https://orcid.org/0000-0001-6864-0547","affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Padova, Padova 35128, Italy","institution_ids":["https://openalex.org/I138689650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029164653","display_name":"Angelo Avogaro","orcid":"https://orcid.org/0000-0002-1177-0516","observed_orcids":["https://orcid.org/0000-0002-1177-0516"]},"institutions":[{"id":"https://openalex.org/I138689650","display_name":"University of Padua","ror":"https://ror.org/00240q980","country_code":"IT","type":"education","lineage":["https://openalex.org/I138689650"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Angelo Avogaro","raw_affiliation_strings":["Department of Medicine, University of Padova, Padova 35128, Italy"],"raw_orcid":"https://orcid.org/0000-0002-1177-0516","affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Padova, Padova 35128, Italy","institution_ids":["https://openalex.org/I138689650"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027393457","display_name":"Gian Paolo Fadini","orcid":"https://orcid.org/0000-0002-6510-2097","observed_orcids":["https://orcid.org/0000-0002-6510-2097"]},"institutions":[{"id":"https://openalex.org/I138689650","display_name":"University of Padua","ror":"https://ror.org/00240q980","country_code":"IT","type":"education","lineage":["https://openalex.org/I138689650"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gian Paolo Fadini","raw_affiliation_strings":["Department of Medicine, University of Padova, Padova 35128, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, University of Padova, Padova 35128, Italy","institution_ids":["https://openalex.org/I138689650"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5087917482"],"corresponding_institution_ids":["https://openalex.org/I138689650"],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":0.5,"has_fulltext":true,"cited_by_count":30,"citation_normalized_percentile":{"value":0.49019016,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"Volume 13","issue":null,"first_page":"4221","last_page":"4234"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8859999775886536},{"id":"https://openalex.org/keywords/real-world-study","display_name":"real-world study","score":0.7850000262260437},{"id":"https://openalex.org/keywords/cardiovascular-outcomes","display_name":"cardiovascular outcomes","score":0.6370000243186951},{"id":"https://openalex.org/keywords/efficacy-versus-effectiveness","display_name":"efficacy versus effectiveness","score":0.6660000085830688},{"id":"https://openalex.org/keywords/underrepresented-groups","display_name":"underrepresented groups","score":0.7400000095367432},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.7200000286102295},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.746999979019165},{"id":"https://openalex.org/keywords/dose-titration","display_name":"dose titration","score":0.7639999985694885},{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.7760000228881836},{"id":"https://openalex.org/keywords/albiglutide","display_name":"albiglutide","score":0.847000002861023},{"id":"https://openalex.org/keywords/exenatide-once-weekly","display_name":"exenatide once weekly","score":0.9300000071525574},{"id":"https://openalex.org/keywords/dulaglutide","display_name":"dulaglutide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/semaglutide","display_name":"semaglutide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.5559999942779541},{"id":"https://openalex.org/keywords/mortality-reduction","display_name":"mortality reduction","score":0.47099998593330383},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C2779829264","wikidata":"https://www.wikidata.org/wiki/Q21011228","display_name":"Dulaglutide","level":5,"score":0.8415430188179016},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.8279682397842407},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7799225449562073},{"id":"https://openalex.org/C2909862629","wikidata":"https://www.wikidata.org/wiki/Q27261089","display_name":"Semaglutide","level":5,"score":0.7314431667327881},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.6624433994293213},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.6114014387130737},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5941477417945862},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4862712621688843},{"id":"https://openalex.org/C185280430","wikidata":"https://www.wikidata.org/wiki/Q14909910","display_name":"Glucagon-like peptide 1 receptor","level":4,"score":0.48208433389663696},{"id":"https://openalex.org/C2776442814","wikidata":"https://www.wikidata.org/wiki/Q6659956","display_name":"Lixisenatide","level":5,"score":0.4604725241661072},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4295560121536255},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4182780086994171},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.4161161780357361},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33781832456588745},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.29744306206703186},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.1971769630908966},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.16531607508659363},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.1233072578907013},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.09115085005760193},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.2147/dmso.s216054","doi":"https://doi.org/10.2147/dmso.s216054","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s216054","pdf_url":"https://www.dovepress.com/getfile.php?fileID=63494","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7665457","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7665457/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Metab Syndr Obes","raw_type":"Text"},{"id":"pmid:33204129","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33204129","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, metabolic syndrome and obesity : targets and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:dc598af776a743eeb3d537f5ebd78e23","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/dc598af776a743eeb3d537f5ebd78e23","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity, Vol Volume 13, Pp 4221-4234 (2020)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/59057","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/long-acting-injectable-glp-1-receptor-agonists-for-the-treatment-of-ad-peer-reviewed-article-DMSO","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Review"},{"id":"pmh:oai:www.research.unipd.it:11577/3363248","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/11577/3363248","pdf_url":null,"source":{"id":"https://openalex.org/S4306402547","display_name":"Padua Research Archive (University of Padova)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I138689650","host_organization_name":"University of Padua","host_organization_lineage":["https://openalex.org/I138689650"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/dmso.s216054","doi":"https://doi.org/10.2147/dmso.s216054","is_oa":true,"landing_page_url":"https://doi.org/10.2147/dmso.s216054","pdf_url":"https://www.dovepress.com/getfile.php?fileID=63494","source":{"id":"https://openalex.org/S176615914","display_name":"Diabetes Metabolic Syndrome and Obesity","issn_l":"1178-7007","issn":["1178-7007"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3099387352.pdf","grobid_xml":"https://content.openalex.org/works/W3099387352.grobid-xml"},"referenced_works_count":86,"referenced_works":["https://openalex.org/W1845661996","https://openalex.org/W1978138475","https://openalex.org/W2007221722","https://openalex.org/W2050153005","https://openalex.org/W2054981500","https://openalex.org/W2056496210","https://openalex.org/W2067732792","https://openalex.org/W2073192039","https://openalex.org/W2104252114","https://openalex.org/W2114938072","https://openalex.org/W2118032584","https://openalex.org/W2152984355","https://openalex.org/W2166269970","https://openalex.org/W2196942236","https://openalex.org/W2415073266","https://openalex.org/W2425644022","https://openalex.org/W2466620119","https://openalex.org/W2519510391","https://openalex.org/W2531269403","https://openalex.org/W2552473439","https://openalex.org/W2563047690","https://openalex.org/W2566204916","https://openalex.org/W2572398654","https://openalex.org/W2586129535","https://openalex.org/W2595744872","https://openalex.org/W2604152120","https://openalex.org/W2610311410","https://openalex.org/W2620356640","https://openalex.org/W2746628081","https://openalex.org/W2751938332","https://openalex.org/W2752707491","https://openalex.org/W2767408736","https://openalex.org/W2770623194","https://openalex.org/W2774157762","https://openalex.org/W2774952509","https://openalex.org/W2787255324","https://openalex.org/W2793207362","https://openalex.org/W2793927060","https://openalex.org/W2800926943","https://openalex.org/W2894746763","https://openalex.org/W2894993577","https://openalex.org/W2896668644","https://openalex.org/W2901445799","https://openalex.org/W2902803248","https://openalex.org/W2906043599","https://openalex.org/W2909633566","https://openalex.org/W2912733453","https://openalex.org/W2913246107","https://openalex.org/W2921016204","https://openalex.org/W2925194642","https://openalex.org/W2936886646","https://openalex.org/W2942132427","https://openalex.org/W2948519518","https://openalex.org/W2948612418","https://openalex.org/W2953049681","https://openalex.org/W2953431890","https://openalex.org/W2965089458","https://openalex.org/W2968054001","https://openalex.org/W2968073288","https://openalex.org/W2969552970","https://openalex.org/W2971469752","https://openalex.org/W2971911180","https://openalex.org/W2974008202","https://openalex.org/W2985391137","https://openalex.org/W2991652243","https://openalex.org/W2995527943","https://openalex.org/W3000578848","https://openalex.org/W3006019089","https://openalex.org/W3007606426","https://openalex.org/W3008898784","https://openalex.org/W3009151641","https://openalex.org/W3014755863","https://openalex.org/W3015221236","https://openalex.org/W3016916224","https://openalex.org/W3033887523","https://openalex.org/W3034401538","https://openalex.org/W3034500555","https://openalex.org/W3034514454","https://openalex.org/W3035185478","https://openalex.org/W3037339885","https://openalex.org/W3043523396","https://openalex.org/W3047532175","https://openalex.org/W4232818745","https://openalex.org/W4240338964","https://openalex.org/W4253996779","https://openalex.org/W7225801607"],"related_works":["https://openalex.org/W4414902918","https://openalex.org/W4406210298","https://openalex.org/W4408736285","https://openalex.org/W4361829012","https://openalex.org/W3045885164","https://openalex.org/W7154508229","https://openalex.org/W4380151351","https://openalex.org/W3034514454","https://openalex.org/W4220887391","https://openalex.org/W3008859491"],"abstract_inverted_index":{"Randomized":[0],"controlled":[1],"trials":[2],"(RCTs)":[3],"have":[4,59],"consistently":[5],"shown":[6],"glycemic":[7],"and":[8,23,35,209,287],"extra-glycemic":[9],"benefits":[10,132],"of":[11,27,32,46,103,123,133,227,239,293],"long-acting":[12],"injectable":[13],"glucagon-like-peptide-1":[14],"receptor":[15],"agonists":[16],"(GLP-1RAs,":[17],"liraglutide,":[18],"albiglutide,":[19],"exenatide":[20],"once-weekly,":[21],"dulaglutide,":[22],"semaglutide)":[24],"in":[25,29,91,98,106,114,121,127,136,202,225,231],"terms":[26],"reduction":[28],"the":[30,44,65,92,101,107,118,130,191,214,237,282],"rates":[31],"cardiovascular":[33,131,274],"events":[34],"mortality":[36],"among":[37],"patients":[38,124,228],"with":[39,89,161,188,261,264],"type":[40],"2":[41],"diabetes.":[42],"Recently,":[43],"analyses":[45],"large":[47],"datasets":[48],"collecting":[49],"routinely-accumulated":[50],"data":[51],"from":[52,68,269],"clinical":[53,197],"practice":[54],"(ie,":[55],"real-world":[56,207],"studies,":[57],"RWS)":[58],"provided":[60],"new":[61],"opportunities":[62],"to":[63,95,111,277],"complement":[64],"information":[66,185],"obtained":[67],"RCTs.":[69,232],"In":[70,233],"this":[71],"narrative":[72],"review,":[73],"we":[74],"addressed":[75],"clinically":[76],"relevant":[77],"questions":[78],"that":[79,112,219,246],"might":[80,247],"be":[81],"answered":[82],"by":[83,146],"well-conducted":[84],"RWS:":[85],"are":[86],"subjects":[87,200],"treated":[88],"GLP-1RAs":[90,134,165,252,262],"\"real-world\"":[93],"similar":[94,110,120],"those":[96,205],"included":[97],"RCTs?":[99,128],"Is":[100,117],"performance":[102],"GLP-1RA":[104,220],"observed":[105],"RWS":[108,181,194,217,235,256,270,286],"(effectiveness)":[109],"described":[113,271],"RCTs":[115,203,288],"(efficacy)?":[116],"effectiveness":[119,221],"population":[122],"generally":[125],"under-represented":[126],"Are":[129],"confirmed":[135],"RWS?":[137],"We":[138],"also":[139],"describe":[140],"a":[141,211,272],"few":[142],"comparisons":[143],"currently":[144],"un-explored":[145],"specific":[147],"RCTs,":[148],"such":[149],"as":[150],"direct":[151],"comparison":[152],"between":[153,164,199],"different":[154,196,291],"administration":[155],"strategies":[156],"(eg,":[157,242],"fixed-":[158],"versus":[159,166,171,204],"flexible-combination":[160],"basal-insulin)":[162],"or":[163,170,244],"dipeptidyl-peptidase-4":[167],"inhibitor":[168],"(DDP4i)":[169],"sodium/glucose":[172],"cotransporter-2":[173],"inhibitors":[174],"(SGLT-2i)":[175],"on":[176,186],"hard":[177],"cardio-renal":[178,259],"outcomes.":[179],"Altogether,":[180],"provide":[182],"highly":[183],"informative":[184],"treatment":[187],"GLP-1RAs.":[189],"On":[190,213],"one":[192],"side,":[193],"showed":[195,218],"characteristics":[198],"enrolled":[201],"attending":[206],"clinics":[208],"receiving":[210],"GLP-1RA.":[212],"other":[215],"hand,":[216],"is":[222,281],"overall":[223],"consistent":[224],"subgroups":[226],"less":[229],"represented":[230],"addition,":[234],"allowed":[236],"identification":[238],"modifiable":[240],"factors":[241],"titration":[243],"adherence)":[245],"guide":[248],"physicians":[249],"towards":[250],"better":[251,258],"use.":[253],"Finally,":[254],"multiple":[255],"reported":[257],"outcomes":[260],"than":[263],"DPP-4i,":[265],"while":[266],"initial":[267],"findings":[268],"weaker":[273],"protection":[275],"compared":[276],"SGLT-2i.":[278],"Therefore,":[279],"there":[280],"need":[283],"for":[284],"further":[285],"comparing":[289],"these":[290],"classes":[292],"glucose":[294],"lowering":[295],"medications.":[296]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3099387352","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2020-11-23T00:00:00"}
